Virtu Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Virtu Financial’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377K	Buy	+702	New	+$360K	0.01%	639
2024 Q1	–	Sell	-4,063	Closed	-$940K	–	1802
2023 Q4	$940K	Buy	+4,063	New	+$711K	0.07%	214
2022 Q3	–	Sell	-3,273	Closed	-$234K	–	2016
2022 Q2	$234K	Buy	+3,273	New	+$241K	0.02%	690
2018 Q4	–	Sell	-1,386	Closed	-$297K	–	1819
2018 Q3	$297K	Buy	+1,386	New	+$348K	0.02%	855
2017 Q4	–	Sell	-6,241	Closed	-$281K	–	2740
2017 Q3	$281K	Buy	+6,241	New	+$117K	0.01%	1456

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Virtu Financial's MDGL Position: Q2 2026 in Review

Virtu Financial opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 702 shares worth $377K. The stake represents 0.01% of the portfolio and ranks #639 among its holdings. This is a return to the name: Virtu Financial previously reported a position in MDGL as recently as Q4 2023.

Virtu Financial first reported a position in MDGL in Q3 2017 and has held it in 5 quarters since. The position peaked at $940K in Q4 2023. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Virtu Financial held 702 shares of Madrigal Pharmaceuticals worth $377K as of Q2 2026.
Madrigal Pharmaceuticals was a new Virtu Financial position in Q2 2026.
Madrigal Pharmaceuticals made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #639 holding.
Virtu Financial first reported a position in Madrigal Pharmaceuticals in Q3 2017 and has held it in 5 quarters since.
Virtu Financial's Madrigal Pharmaceuticals position peaked at $940K in Q4 2023.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.